VNRX shows severe financial deterioration with a 66% cash decline, 57% increase in current liabilities, and worsening equity deficit of $34.2M despite 64% share dilution.
The massive 64% increase in outstanding shares (from 96.5M to 158.5M) combined with plummeting cash reserves suggests the company is burning through capital rapidly and relying heavily on equity dilutions to survive. The deteriorating working capital position and growing debt load indicate serious liquidity constraints that could threaten business continuity.
VNRX's financial position has deteriorated significantly, with cash declining 66% to just $1.1M while current liabilities surged 57% to $12.2M, creating a severe working capital deficit. Despite 40% revenue growth to $1.7M and reduced R&D spending, the company's equity deficit worsened to -$34.2M and total assets shrunk 27%, indicating the business is consuming more capital than it's generating. The 64% dilution in share count reveals heavy reliance on equity financing to fund operations, suggesting potential going concern issues.
Receivables surged 187.4% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Capex reduced 67.7% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Cash declined 65.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Current liabilities surged 57% — significant near-term obligations; verify ability to meet short-term debt.
Current assets declined 49.2% — monitor working capital adequacy and short-term liquidity.
Strong top-line growth of 40% — accelerating demand or successful expansion into new markets.
Debt increased 39.4% — substantial leverage increase; assess whether deployed for growth or covering losses.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
R&D spending cut 30% — could signal cost discipline or concerning reduction in innovation investment.
Total assets contracted 26.6% — asset sales, write-downs, or balance sheet optimization underway.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →